Can you manipulate your brain to stop your food cravings?

New research conducted on the brains of mice suggest it may be possible to "switch off" particular food cravings.

woman staring at dessert

What causes food cravings and how can you avoid them?

Photo by AshTproductions on Shutterstock
  • A food craving can be described as an intense desire for a specific food. This desire can seem uncontrollable at times.
  • Emerging research suggests it may be possible to "switch off" the pleasure feelings we experience from eating certain foods, which could curb cravings.
  • This could be groundbreaking in terms of new eating disorder treatments.


Where do food cravings come from?

"We've all experienced hunger (where eating anything will suffice), but what makes food cravings different from hunger is how specific they are," writes Science Daily. "When people crave a specific food, they have vivid images of that food. Results of one study showed that the strength of participants' cravings was linked to how vividly they imagined the food."

Can you manage (or completely avoid) certain food cravings? Emerging research suggests it may be possible to switch off the pleasure feelings we experience from eating certain foods, which could curb cravings.

    Why do we crave certain foods?

    illustration of pencil erasing road to meats and fried food

    Can you "erase" food cravings? New research suggests it's possible..

    Photo by Lightspring on Shutterstock

    A food craving can be described as an intense desire for a specific food, and this desire can seem uncontrollable at times. The person experiencing the craving may be left feeling unsatisfied until they experience that particular food or taste.

    Food cravings are caused by the regions in the brain that are responsible for memory, pleasure, and reward. Hormone imbalances can also cause food cravings to spike. Additionally, your emotions may be involved in producing food cravings, especially if you find yourself eating for comfort reasons. Emotional eating can quickly turn into a very bad habit and generally happens when someone is eating to stifle or soothe negative feelings.

    Food provides satisfaction, so replacing a negative emotion (such as loneliness) with a positive emotion (such as joy from eating a piece of chocolate cake) seems like a good idea. When you experience satisfaction, your brain is flooded with dopamine, which then adds to the motivation you have to keep doing that thing (eating) that is making you feel good.

    Once this happens a few times, it can become truly difficult to distinguish true physical hunger from emotional hunger.

    Physical hunger slowly develops over time and you will desire a variety of different foods. You will feel the sensation of being full (when you've eaten enough) and take that as a cue to stop eating.

    Emotional hunger, on the other hand, comes on very suddenly and is usually pinpointed to a certain food that makes you feel good while eating is. You may binge on food and not realize the sensation of being full, which tends to lead to feelings of shame and guilt.

    Food cravings can become a major roadblock in maintaining a healthy weight and diet. But what if there was a way to "switch off" the cravings?

    Scientists switch off pleasure from food in the brains of mice

    amygdala food cravings close up of amygdala region of the brain

    Research has revealed it's possible to "switch off" food cravings area of the brain in mice.

    Image by CLIPAREA l Custom media

    New research (in mice) has revealed that the brain's underlying desire for sweet (and it's alternative distaste for bitter) can be "erased" by manipulating the neurons in the amygdala.

    This 2017 study suggests that the brain's complex taste system (which produces an array of thoughts, memories, and emotions when tasting food) is actually made up of discrete units that can be individually isolated, modified, or even removed.

    For this experiment, scientists focused on the sweet and bitter tastes and the amygdala, the region of the brain known to be key in making value judgments about sensory information. Previous research has shown that the amygdala connects directly to the taste cortex.

    The researchers performed several tests in which the "sweet" or "bitter" connections to the amygdala were artificially switched on, like flicking a series of light switches.

    When the sweet connections were turned on, the mice responded to water just as if it were sugar. By manipulating these connections, the researchers were able to change the perceived quality of the taste.

    In contrast, when these connections were switched off but the taste cortex remained untouched, the mice could still recognize and distinguish sweet from bitter, but now lacked the basic emotional reaction to each taste.

    Dr. Li Wang, Ph.D, a postdoctoral research scientist and the paper's first author, explained to Science Daily: "It would be like taking a bite of your favorite chocolate cake but not deriving any enjoyment from doing so. After a few bites, you may stop eating, whereas otherwise you would have scarfed it down."

    This research is quite extraordinary, as typically the identity of food and the pleasure we derive from eating that food are intertwined. This study proves that they are separate components that could be isolated from each other and then manipulated separately.

    This could be groundbreaking research in terms of advancing the treatments of certain eating disorders.

    Optimize Your Brain: The Science of Smarter Eating | Dr. Drew Ramsey



      U.S. Navy controls inventions that claim to change "fabric of reality"

      Inventions with revolutionary potential made by a mysterious aerospace engineer for the U.S. Navy come to light.

      U.S. Navy ships

      Credit: Getty Images
      Surprising Science
      • U.S. Navy holds patents for enigmatic inventions by aerospace engineer Dr. Salvatore Pais.
      • Pais came up with technology that can "engineer" reality, devising an ultrafast craft, a fusion reactor, and more.
      • While mostly theoretical at this point, the inventions could transform energy, space, and military sectors.
      Keep reading Show less

      Why so gassy? Mysterious methane detected on Saturn’s moon

      Scientists do not know what is causing the overabundance of the gas.

      An impression of NASA's Cassini spacecraft flying through a water plume on the surface of Saturn's moon Enceladus.

      Credit: NASA
      Surprising Science
      • A new study looked to understand the source of methane on Saturn's moon Enceladus.
      • The scientists used computer models with data from the Cassini spacecraft.
      • The explanation could lie in alien organisms or non-biological processes.
      Keep reading Show less

      CRISPR therapy cures first genetic disorder inside the body

      It marks a breakthrough in using gene editing to treat diseases.

      Credit: National Cancer Institute via Unsplash
      Technology & Innovation

      This article was originally published by our sister site, Freethink.

      For the first time, researchers appear to have effectively treated a genetic disorder by directly injecting a CRISPR therapy into patients' bloodstreams — overcoming one of the biggest hurdles to curing diseases with the gene editing technology.

      The therapy appears to be astonishingly effective, editing nearly every cell in the liver to stop a disease-causing mutation.

      The challenge: CRISPR gives us the ability to correct genetic mutations, and given that such mutations are responsible for more than 6,000 human diseases, the tech has the potential to dramatically improve human health.

      One way to use CRISPR to treat diseases is to remove affected cells from a patient, edit out the mutation in the lab, and place the cells back in the body to replicate — that's how one team functionally cured people with the blood disorder sickle cell anemia, editing and then infusing bone marrow cells.

      Bone marrow is a special case, though, and many mutations cause disease in organs that are harder to fix.

      Another option is to insert the CRISPR system itself into the body so that it can make edits directly in the affected organs (that's only been attempted once, in an ongoing study in which people had a CRISPR therapy injected into their eyes to treat a rare vision disorder).

      Injecting a CRISPR therapy right into the bloodstream has been a problem, though, because the therapy has to find the right cells to edit. An inherited mutation will be in the DNA of every cell of your body, but if it only causes disease in the liver, you don't want your therapy being used up in the pancreas or kidneys.

      A new CRISPR therapy: Now, researchers from Intellia Therapeutics and Regeneron Pharmaceuticals have demonstrated for the first time that a CRISPR therapy delivered into the bloodstream can travel to desired tissues to make edits.

      We can overcome one of the biggest challenges with applying CRISPR clinically.

      —JENNIFER DOUDNA

      "This is a major milestone for patients," Jennifer Doudna, co-developer of CRISPR, who wasn't involved in the trial, told NPR.

      "While these are early data, they show us that we can overcome one of the biggest challenges with applying CRISPR clinically so far, which is being able to deliver it systemically and get it to the right place," she continued.

      What they did: During a phase 1 clinical trial, Intellia researchers injected a CRISPR therapy dubbed NTLA-2001 into the bloodstreams of six people with a rare, potentially fatal genetic disorder called transthyretin amyloidosis.

      The livers of people with transthyretin amyloidosis produce a destructive protein, and the CRISPR therapy was designed to target the gene that makes the protein and halt its production. After just one injection of NTLA-2001, the three patients given a higher dose saw their levels of the protein drop by 80% to 96%.

      A better option: The CRISPR therapy produced only mild adverse effects and did lower the protein levels, but we don't know yet if the effect will be permanent. It'll also be a few months before we know if the therapy can alleviate the symptoms of transthyretin amyloidosis.

      This is a wonderful day for the future of gene-editing as a medicine.

      —FYODOR URNOV

      If everything goes as hoped, though, NTLA-2001 could one day offer a better treatment option for transthyretin amyloidosis than a currently approved medication, patisiran, which only reduces toxic protein levels by 81% and must be injected regularly.

      Looking ahead: Even more exciting than NTLA-2001's potential impact on transthyretin amyloidosis, though, is the knowledge that we may be able to use CRISPR injections to treat other genetic disorders that are difficult to target directly, such as heart or brain diseases.

      "This is a wonderful day for the future of gene-editing as a medicine," Fyodor Urnov, a UC Berkeley professor of genetics, who wasn't involved in the trial, told NPR. "We as a species are watching this remarkable new show called: our gene-edited future."

      Quantcast